{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:38:16Z","timestamp":1780076296467,"version":"3.54.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP135260"],"award-info":[{"award-number":["MOP135260"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP210232"],"award-info":[{"award-number":["MOP210232"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R\u00e9seau SIDA et Maladies Infectieuses du Fonds de la Recherche en Sant\u00e9 du Qu\u00e9bec","award":["FRSQ5227"],"award-info":[{"award-number":["FRSQ5227"]}]},{"DOI":"10.13039\/100009874","name":"University of Sherbrooke","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Charles Lemoyne Hospital Foundation"},{"name":"University of Sherbrooke Foundation in Qu\u00e9bec, Canada"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.drugpo.2015.04.013","type":"journal-article","created":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T01:14:55Z","timestamp":1430010895000},"page":"970-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention"],"prefix":"10.1016","volume":"26","author":[{"given":"Andreea Adelina","family":"Artenie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lise","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5676-9634","authenticated-orcid":false,"given":"Geng","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Bamvita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Puzhko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugpo.2015.04.013_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09595230220119327","article-title":"Peer-delivered hepatitis C testing and counselling: A means of improving the health of injecting drug users","volume":"21","author":"Aitken","year":"2002","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2015.04.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.12393","article-title":"Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: Room for improvement","author":"Artenie","year":"2015","journal-title":"Journal of Viral Hepatitis"},{"issue":"1","key":"10.1016\/j.drugpo.2015.04.013_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugpo.2013.08.005","article-title":"Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study","volume":"25","author":"Aspinall","year":"2014","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2015.04.013_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-11-1","article-title":"Barriers and facilitators of hepatitis C screening among people who inject drugs: A multi-city, mixed-methods study","volume":"11","author":"Barocas","year":"2014","journal-title":"Harm Reduction Journal"},{"issue":"7","key":"10.1016\/j.drugpo.2015.04.013_bib0025","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1360-0443.2012.03803.x","article-title":"The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users","volume":"107","author":"Bruneau","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.drugpo.2015.04.013_bib0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cit938","article-title":"Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: A longitudinal study","volume":"58","author":"Bruneau","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.drugpo.2015.04.013_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0376-8716(94)01058-S","article-title":"Cocaine use and HIV risk behavior in methadone maintenance patients","volume":"37","author":"Bux","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"RR-05","key":"10.1016\/j.drugpo.2015.04.013_bib0040","first-page":"1","article-title":"Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: Summary guidance from CDC and the U.S. Department of Health and Human Services","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.drugpo.2015.04.013_bib0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"},{"issue":"3","key":"10.1016\/j.drugpo.2015.04.013_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2015.04.013_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1497.2003.10601.x","article-title":"Effect of primary medical care on addiction and medical severity in substance abuse treatment programs","volume":"18","author":"Friedmann","year":"2003","journal-title":"Journal of General Internal Medicine"},{"issue":"6","key":"10.1016\/j.drugpo.2015.04.013_bib0060","doi-asserted-by":"crossref","first-page":"e97726","DOI":"10.1371\/journal.pone.0097726","article-title":"Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996\u20132012","volume":"9","author":"Grebely","year":"2014","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.drugpo.2015.04.013_bib0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"10.1016\/j.drugpo.2015.04.013_bib0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"12","key":"10.1016\/j.drugpo.2015.04.013_bib0075","first-page":"900","article-title":"Under the watchful eye of \u2018a benevolent dictator\u2019 \u2013 General practitioner and patient experiences of hepatitis C treatment initiation and shared-care in general practice","volume":"42","author":"Hopwood","year":"2013","journal-title":"Australian Family Physician"},{"issue":"2","key":"10.1016\/j.drugpo.2015.04.013_bib0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3122\/jabfm.2014.02.130165","article-title":"Hepatitis C for primary care physicians","volume":"27","author":"Huffman","year":"2014","journal-title":"Journal of the American Board of Family Medicine"},{"issue":"2","key":"10.1016\/j.drugpo.2015.04.013_bib0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugpo.2011.08.005","article-title":"The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature","volume":"23","author":"Islam","year":"2012","journal-title":"International Journal of Drug Policy"},{"issue":"8","key":"10.1016\/j.drugpo.2015.04.013_bib0090","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2105\/AJPH.2012.301206","article-title":"Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: A linkage study","volume":"103","author":"Iversen","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.drugpo.2015.04.013_bib0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/09540121.2011.596515","article-title":"Distributive sharing among HIV-HCV co-infected injecting drug users: The preventive role of trust in one's physician","volume":"24","author":"Jauffret-Roustide","year":"2012","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugpo.2015.04.013_bib0100","first-page":"9270","article-title":"Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting","author":"Kim","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugpo.2015.04.013_bib0105","series-title":"Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection \u2013 \u00c9pid\u00e9miologie du VIH de 1995 \u00e0 2012 \u2013 \u00c9pid\u00e9miologie du VHC de 2003 \u00e0 2012","author":"Leclerc","year":"2014"},{"key":"10.1016\/j.drugpo.2015.04.013_bib0110","series-title":"A cross-Canada scan of methadone maintenance treatment policy developments","author":"Luce","year":"2011"},{"issue":"1","key":"10.1016\/j.drugpo.2015.04.013_bib0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2014","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2015.04.013_bib0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/sextrans-2011-050130","article-title":"The role of the general practitioner in the Australian approach to HIV care: Interviews with \u2018key informants\u2019 from government, non-government and professional organisations","volume":"88","author":"Newman","year":"2012","journal-title":"Sexually Transmitted Infections"},{"issue":"12","key":"10.1016\/j.drugpo.2015.04.013_bib0125","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users","volume":"109","author":"Nolan","year":"2014","journal-title":"Addiction"},{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2015.04.013_bib0130","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/cid\/cit300","article-title":"Injection drug use and hepatitis C virus infection in young adult injectors: Using evidence to inform comprehensive prevention","volume":"57","author":"Page","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.04.013_bib0135","series-title":"I-Track: Enhanced surveillance of risk behaviors among injection drug users in Canada. Phase I report","author":"Public Health Agency of Canada","year":"2006"},{"key":"10.1016\/j.drugpo.2015.04.013_bib0140","series-title":"Primary care management of chronic Hepatitis C: Professional desk reference 2009","author":"Public Health Agency of Canada","year":"2009"},{"issue":"9","key":"10.1016\/j.drugpo.2015.04.013_bib0145","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3109\/10826084.2011.552932","article-title":"The growing popularity of prescription opioid injection in downtown Montreal: New challenges for harm reduction","volume":"46","author":"Roy","year":"2011","journal-title":"Substance Use and Misuse"},{"issue":"3","key":"10.1016\/j.drugpo.2015.04.013_bib0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1475-6773.2004.00246.x","article-title":"Linkage with primary medical care in a prospective cohort of adults with addictions in inpatient detoxification: Room for improvement","volume":"39","author":"Saitz","year":"2004","journal-title":"Health Services Research"},{"issue":"515","key":"10.1016\/j.drugpo.2015.04.013_bib0155","first-page":"444","article-title":"The prescribing of methadone and other opioids to addicts: National survey of GPs in England and Wales","volume":"55","author":"Strang","year":"2005","journal-title":"British Journal of General Practice"},{"issue":"Suppl. 5","key":"10.1016\/j.drugpo.2015.04.013_bib0160","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1086\/427445","article-title":"Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users","volume":"40","author":"Strathdee","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1016\/j.drugpo.2015.04.013_bib0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/apc.2010.0142","article-title":"Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: A qualitative exploration","volume":"24","author":"Swan","year":"2010","journal-title":"AIDS Patient Care and STDS"},{"key":"10.1016\/j.drugpo.2015.04.013_bib0170","series-title":"Guidance for the prevention, testing, treatment and management of hepatitis C in primary care","author":"The Royal College of General Practitioners","year":"2007"},{"issue":"1\u20133","key":"10.1016\/j.drugpo.2015.04.013_bib0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2010.11.018","article-title":"Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs","volume":"116","author":"Treloar","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.drugpo.2015.04.013_bib0180","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.drugpo.2015.04.013_bib0185","series-title":"The guide to clinical preventive services, 2014. Recommendations of the U.S. Preventive Services Task Force","author":"U.S. Preventive Services Task Force","year":"2014"},{"issue":"7","key":"10.1016\/j.drugpo.2015.04.013_bib0190","doi-asserted-by":"crossref","first-page":"e103345","DOI":"10.1371\/journal.pone.0103345","article-title":"Hepatitis C virus infection epidemiology among people who inject drugs in Europe: A systematic review of data for scaling up treatment and prevention","volume":"9","author":"Wiessing","year":"2014","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.drugpo.2015.04.013_bib0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1503\/cmaj.1030034","article-title":"Hepatitis C: A review for primary care physicians","volume":"174","author":"Wong","year":"2006","journal-title":"CMAJ: Canadian Medical Association Journal"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395915001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395915001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T23:59:58Z","timestamp":1566604798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395915001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0955395915001243"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.04.013","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}